GlassScriptPhysician profile
Bitu H Sheth
NPI 1114361698
$3,099.04
in general payments reported to CMS, 2019-2025
19 companies · $1,155 in 2025
The $1,155 reported for 2025 was more than what 85% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $358 · 2022: $336 · 2023: $151 · 2024: $1,100 · 2025: $1,155.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,157 · Travel and Lodging: $249.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,157.04 |
| Travel and Lodging | $248.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,046.48 | 2021-2025 | |
| Nevro Corp. | $594.17 | 2021-2024 | Senza |
| Globus Medical, INC. | $327.59 | 2025 | Senza |
| Medtronic, INC. | $294.35 | 2025 | Kyphon Express II Kyphopak Tray, Accurian |
| Pfizer INC. | $132.67 | 2021-2025 | |
| Lundbeck LLC | $121.47 | 2021-2025 | Vyepti |
| Amgen INC. | $90.28 | 2021-2022 | |
| Biohaven Pharmaceuticals, INC. | $87.49 | 2021 | |
| Grt US Holding, INC. | $76.27 | 2022 | |
| Nalu Medical, INC. | $56.28 | 2022-2024 | Nalu Neurostimulation System |
| Scilex Pharmaceuticals INC. | $55.46 | 2021-2023 | Ztlido |
| Vertex Pharmaceuticals Incorporated | $48.30 | 2024-2025 | |
| Novartis Pharmaceuticals Corporation | $38.11 | 2021 | |
| Abbott Laboratories | $32.55 | 2024 | Eterna |
| Spr Therapeutics, INC | $26.78 | 2024 | Sprint Pns System |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biodelivery Sciences International, INC. | $24.20 | 2021 | |
| Lilly USA, LLC | $17.62 | 2024 | Emgality, Reyvow |
| Allergan, INC. | $14.60 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $14.37 | 2024 | Ajovy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bitu Sheth listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.